Chelation therapy is a safe, effective, and relatively inexpensive treatment to restore blood flow in victims of atherosclerosis (or hardening of the arteries) without surgery. Chelation therapy involves intravenous infusion of a prescription medicine (used in an off-label fashion) called ethylenediamine tetraacetic acid (EDTA). Dr. Casañas has successfully used chelation therapy in patients who have chronic fatigue immune dysfunction syndrome, macular degeneration, fibromyalgia, chronic infections, degenerative disease, autoimmune disease (multiple sclerosis, rheumatoid arthritis, etc.), and patients who are unwilling to undergo surgical coronary bypass or angioplasty, are not good candidates for such, or have had already too many failed attempts with such an approach. Another likely candidate might also be someone who has a strong family history of coronary artery disease and would like to do everything possible to even out the overwhelming odds.
Most chelation practitioners or chelation physicians will suggest undergoing 30 standard preventive treatments and a quarterly chelation session for a long term maintenance program. Chelation sessions generally take about two to three hours to administer after starting an intravenous line and are usually performed in a comfortable living room type setting in a doctor’s office.
There are very extensive studies currently going on now to definitively prove that chelation therapy can be a useful adjunct in the treatment of coronary artery disease. Not enough research has been generated for other therapeutic applications of chelation such as autoimmune dysfunction, chronic fatigue, etc. Dr. Casañas predicts that these studies will not be forthcoming since they are difficult to perform and EDTA is not a patented drug. Nevertheless, EDTA chelation is a reasonable and safe alternative to doing nothing until surgery.